XML 70 R44.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Business segments and other information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Segment Reporting [Abstract] |
Business segments and other information | The following tables present the Company’s segment results for the years ended December 31, 2017, 2016 and 2015:
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
| (Dollars in thousands)
Revenue |  |  |  |  |
Vascular North America | $ | 313,618 |  |  | $ | 295,206 |  |  | $ | 284,097 |
Interventional North America | 220,611 |  |  | 82,431 |  |  | 75,196 |
Anesthesia North America | 197,982 |  |  | 198,772 |  |  | 189,297 |
Surgical North America | 175,216 |  |  | 172,223 |  |  | 161,230 |
EMEA | 552,722 |  |  | 510,934 |  |  | 514,443 |
Asia | 269,208 |  |  | 249,416 |  |  | 241,726 |
OEM | 182,967 |  |  | 160,990 |  |  | 149,399 |
All other | 233,979 |  |  | 198,055 |  |  | 194,302 |
Consolidated net revenues | $ | 2,146,303 |  |  | $ | 1,868,027 |  |  | $ | 1,809,690 |
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
| (Dollars in thousands)
Operating Profit |  |  |  |  |
Vascular North America | $ | 77,036 |  |  | $ | 77,122 |  |  | $ | 59,441 |
Interventional North America | 25,972 |  |  | 13,264 |  |  | 5,800 |
Anesthesia North America | 62,901 |  |  | 55,544 |  |  | 48,311 |
Surgical North America | 63,931 |  |  | 56,608 |  |  | 52,529 |
EMEA | 92,430 |  |  | 84,392 |  |  | 92,326 |
Asia | 75,637 |  |  | 75,770 |  |  | 67,887 |
OEM | 41,578 |  |  | 33,641 |  |  | 33,162 |
All other | 11,142 |  |  | 26,486 |  |  | 28,399 |
Total segment operating profit (1) | 450,627 |  |  | 422,827 |  |  | 387,855 |
Unallocated expenses (2) | (78,348 | ) |  | (103,374 | ) |  | (71,964 | )
Income from continuing operations before interest, loss on extinguishment of debt and taxes | $ | 372,279 |  |  | $ | 319,453 |  |  | $ | 315,891 |
(1) | Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2) | Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring and impairment charges and gain on sale of assets.
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
| (Dollars in thousands)
Depreciation and Amortization |  |  |  |  |
Vascular North America | $ | 31,058 |  |  | $ | 35,117 |  |  | $ | 35,259 |
Interventional North America | 29,108 |  |  | 6,993 |  |  | 7,823 |
Anesthesia North America | 8,573 |  |  | 10,932 |  |  | 7,089 |
Surgical North America | 8,694 |  |  | 10,459 |  |  | 12,289 |
EMEA | 34,322 |  |  | 30,505 |  |  | 32,178 |
Asia | 11,868 |  |  | 11,275 |  |  | 11,382 |
OEM | 8,337 |  |  | 8,404 |  |  | 6,834 |
All other | 28,378 |  |  | 14,661 |  |  | 12,480 |
Consolidated depreciation and amortization | $ | 160,338 |  |  | $ | 128,346 |  |  | $ | 125,334 |
Total Net Revenues and Total Net Property, Plant and Equipment by Geographic Region | The following tables provide total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2017, 2016 and 2015:
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
| (Dollars in thousands)
Net revenues (based on the Company's selling location): |  |  |  |  |
United States | $ | 1,254,825 |  |  | $ | 1,018,786 |  |  | $ | 967,819 |
Europe | 591,370 |  |  | 567,320 |  |  | 570,672 |
Asia and Asia Pacific | 220,110 |  |  | 208,841 |  |  | 196,796 |
All other | 79,998 |  |  | 73,080 |  |  | 74,403 |
| $ | 2,146,303 |  |  | $ | 1,868,027 |  |  | $ | 1,809,690 |
Net property, plant and equipment: |  |  |  |  |
United States | $ | 216,568 |  |  | $ | 167,167 |  |  | $ | 178,895 |
Malaysia | 43,730 |  |  | 31,415 |  |  | 33,777 |
Ireland | 43,867 |  |  | 36,569 |  |  | 33,219 |
Czech Republic | 35,715 |  |  | 30,843 |  |  | 32,305 |
All other | 43,119 |  |  | 36,905 |  |  | 37,927 |
| $ | 382,999 |  |  | $ | 302,899 |  |  | $ | 316,123 |

X
- Definition Schedule of revenues and property plant equipment by geographic region. + References No definition available. + Details
Name: | tfx_ScheduleOfRevenuesAndPropertyPlantEquipmentByGeographicRegionTableTableTextBlock
Namespace Prefix: | tfx_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration